Medicine
Vilazodone 40 mg tablet
Vilazodone 40 mg tablet is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Bottle of 30 NDC 46708-234-30 Bottle of 90 NDC 46708-234-90 Bottle of 500 NDC…
Key facts
- Active ingredient (INN)
- Vilazodone
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 500 tablets, 90 tablets and 15 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAccord HealthcareIndiaCiplaIndiaNovadoz PharmaceuticalsIndiaApotexExelan PharmaceuticalsGolden State Medical SupplyNorthStar RxPreferred PharmaceuticalsProficient Rx
- Origin register
- US FDA, United States
- Storage
- Bottle of 30 NDC 46708-234-30 Bottle of 90 NDC 46708-234-90 Bottle of 500 NDC 46708-234-71 Bottle of 1000 NDC 46708-234-91 Vilazodone hydrochloride tablets should be stored at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX24 Vilazodone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 2019
- Identifiers
- RxCUI 1086772, 1086778, 1086784DailyMed set ID 0374fbb1-b0fb-4150-b1e7-92e2b0d32ecf, 8b95b850-8bdf-4255-a691-783d1a94bd07, 658c4bc1-4128-4e0e-8852-b5f68880e8d7 +9NDC 46708-234, 62332-234, 69097-982 +9Application ANDA208202, ANDA208200, ANDA208228 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 46708-234-30 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 500 tablet, film coated in 1 bottle | 46708-234-71 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 90 tablet, film coated in 1 bottle | 46708-234-90 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 1000 tablet, film coated in 1 bottle | 46708-234-91 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 30 tablet, film coated in 1 bottle | 62332-234-30 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 500 tablet, film coated in 1 bottle | 62332-234-71 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 90 tablet, film coated in 1 bottle | 62332-234-90 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 1000 tablet, film coated in 1 bottle | 62332-234-91 | Alembic PharmaceuticalsIndia | 4 June 2022 |
| 30 tablet in 1 bottle | 16729-354-10 | Accord HealthcareIndia | 4 June 2022 |
| 30 tablet, film coated in 1 bottle | 69097-982-02 | CiplaIndia | 23 January 2023 |
| 30 tablet in 1 bottle | 72205-262-30 | Novadoz PharmaceuticalsIndia | 14 July 2023 |
| 30 tablet in 1 bottle | 60505-4374-3 | Apotex | 26 October 2023 |
| 30 tablet, film coated in 1 bottle | 76282-546-30 | Exelan Pharmaceuticals | 1 December 2022 |
| 30 tablet, film coated in 1 bottle | 0480-2043-56 | Teva Pharmaceuticals | 6 June 2022 |
| 30 tablet, film coated in 1 bottle | 51407-917-30 | Golden State Medical Supply | 27 May 2025 |
| 30 tablet in 1 bottle | 72603-815-01 | Northstar Rx | 1 January 2025 |
| 30 tablet in 1 bottle | 68788-8735-3 | Preferred Pharmaceuticals | 16 September 2024 |
| 30 tablet in 1 bottle | 82804-128-30 | Proficient Rx | 19 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 January 2011 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Vilazodone 40 mg tablet.
Other strengths and forms of Vilazodone
Clinical summary
Vilazodone is a prescription medicine indicated for the treatment of major depressive disorder (MDD) in adults. It is available as tablets for oral use. MedsAcross supplies Vilazodone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VilazodoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VIIBRYD prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Vilazodone 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.